What Is Accounting for the Rapid Decline in Cigarette Sales in Japan?

Cummings, Michael; Nahhas, Georges J.; Sweanor, David

doi:10.3390/ijerph17103570

Cited by 42 publications

(28 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…83 In Japan, HTP adoption from 2015 to 2019 was accompanied by cigarette sales declining by a third. 84 In both cases-HTPs in Japan and e-cigarettes in the United States-as sales of reducedrisk products rose, cigarette sales fell.…”

Section: Cigarette Salesmentioning

confidence: 99%

Balancing Consideration of the Risks and Benefits of E-Cigarettes

et al. 2021

View full text Add to dashboard Cite

The topic of e-cigarettes is controversial. Opponents focus on e-cigarettes’ risks for young people, while supporters emphasize the potential for e-cigarettes to assist smokers in quitting smoking. Most US health organizations, media coverage, and policymakers have focused primarily on risks to youths. Because of their messaging, much of the public—including most smokers—now consider e-cigarette use as dangerous as or more dangerous than smoking. By contrast, the National Academies of Science, Engineering, and Medicine concluded that e-cigarette use is likely far less hazardous than smoking. Policies intended to reduce adolescent vaping may also reduce adult smokers’ use of e-cigarettes in quit attempts. Because evidence indicates that e-cigarette use can increase the odds of quitting smoking, many scientists, including this essay’s authors, encourage the health community, media, and policymakers to more carefully weigh vaping’s potential to reduce adult smoking-attributable mortality. We review the health risks of e-cigarette use, the likelihood that vaping increases smoking cessation, concerns about youth vaping, and the need to balance valid concerns about risks to youths with the potential benefits of increasing adult smoking cessation.

show abstract

Section: Cigarette Salesmentioning

confidence: 99%

Balancing Consideration of the Risks and Benefits of E-Cigarettes

et al. 2021

View full text Add to dashboard Cite

show abstract

“…For heat‐not‐burn products, the available data regarding their potential role in aiding smoking cessation is even more limited than for e‐cigarettes. However, there are reports of an accelerated decline in cigarette sales in Japan corresponding to the introduction of heat‐not‐burn products into the market, 100 which might represent their potential in supporting population quitting smoking.…”

Section: Potential To Aid Smoking Cessation/support Harm Reductionmentioning

confidence: 99%

Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame

Benowitz

Helen

Liakoni

2021

The Journal of Clinical Pharma

View full text Add to dashboard Cite

Electronic nicotine delivery systems (ENDS) such as e‐cigarettes and heated tobacco products are novel battery‐operated devices that deliver nicotine without combustion of tobacco. Because cigarette smoking is sustained by nicotine addiction and the toxic combustion products are mainly responsible for the harmful effects of smoking, ENDS could be used to promote smoking cessation while exposing users to lower levels of toxicants compared with conventional cigarettes. The currently available evidence from clinical and observational studies indicates a potential role of e‐cigarettes as smoking cessation aids, although many continue to use e‐cigarettes long after quitting smoking. Nicotine and toxicant delivery vary considerably by device and depend on the characteristics of the e‐liquid formulation. Because smokers tend to titrate their nicotine intake to maintain their desired pharmacologic effects, device and liquid characteristics need to be considered when using ENDS as an aid to quit smoking. Factors potentially limiting their use are the currently still unknown long‐term safety of these products and concerns regarding widespread use among youth. Implications of clinical pharmacology data on ENDS for the cigarette endgame and regulation by the U.S. Food and Drug administration are discussed.

show abstract

“…However, they did not approve that IQOS use reduces the risk of tobacco-related diseases or reduces harm relative to continued cigarette smoking. Notably, in Japan, the introduction and rapid increase in use of HTP [10,11] has led to an acceleration in the decline of cigarette sales [12,13].…”

Section: Introductionmentioning

confidence: 99%

Heated Tobacco Products and Nicotine Pouches: A Survey of People with Experience of Smoking and/or Vaping in the UK

Brose

McDermott

McNeill

2021

IJERPH

View full text Add to dashboard Cite

Background: To gauge the public health impact of new nicotine products, information is needed on use among different populations. Aims were to assess in adults who smoked, vaped, did both or had recently stopped: (1) awareness, ever and current use of heated tobacco products (HTPs) and nicotine pouches (NP), (2) characteristics associated with ever use, (3) reasons for use of and satisfaction with HTPs, (4) characteristics associated with interest in use of HTPs. Methods: Online survey in the UK in 2019, n = 3883. (1) Proportion aware, ever and current (≥monthly) use; (2) ever use regressed onto socio-demographics and smoking/vaping; (3) frequency of reasons for HTP use and satisfaction; (4) interest in trying HTPs regressed onto socio-demographics and smoking/vaping status. Results: Awareness was 34.8% for HTP and 15.9% for NP; current use was 3.2% and 2.7%. Being <45 years, higher education, living in London and currently both smoking and vaping were associated with ever having used the products. Curiosity was the most common reason for HTP use (79.8%) and 72.0% of ever HTP users found them at least as satisfying as smoking. Among those not currently using HTPs, 48.5% expressed any interest—lower among those aged over 65 and higher among those smoking and vaping. Conclusion: In this sample of adults with a history of nicotine use, very few currently used heated tobacco products or nicotine pouches. Satisfaction with and interest in HTPs were substantial. The low level of use is unlikely to substantially reduce the public health impact of smoking.

show abstract

What Is Accounting for the Rapid Decline in Cigarette Sales in Japan?

Cited by 42 publications

References 13 publications

Balancing Consideration of the Risks and Benefits of E-Cigarettes

Balancing Consideration of the Risks and Benefits of E-Cigarettes

Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame

Heated Tobacco Products and Nicotine Pouches: A Survey of People with Experience of Smoking and/or Vaping in the UK

Contact Info

Product

Resources

About